Back
United Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
UTHR
United Therapeutics
Last Price:
$294.33
Seasonality Move:
3.14%
7 Day Trial
ALL ACCESS PASS
$
7
United Therapeutics Stock Forecast
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 33.7% based on the past 26 years of stock performance.
-
United Therapeutics has risen higher in 18 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 69.23%
-
Is United Therapeutics Stock Undervalued?The current United Therapeutics [UTHR] share price is $294.28. The Score for UTHR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 33.7% based on the past 26 years of stock performance.
United Therapeutics Stock Rating
Sell
42
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics overpriced?
-
United Therapeutics has risen higher in 18 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 69.23%
United Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
417.82
52-Week Low:
266.98
Prediction Charts
Market Cap:
13.3B
Price in USD:
294.28
Volume:
2.4M
Beta:
0.52
Technical Analysis
SMA50:
298.82
SMA100:
300.01
SMA200:
331.18
52-Wk Change:
-10.22%
Stock Predictions
-
Is United Therapeutics stock public?Yes, United Therapeutics is a publicly traded company.
-
What is the United Therapeutics stock quote today?The United Therapeutics stock price is 294.28 USD today.
-
How to buy United Therapeutics stock online?You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jul-15 | 297.70 | 293.24 | 300.37 | 291.72 |
| Jul-16 | 295.25 | 298.16 | 299.83 | 295.01 |
| Jul-17 | 296.80 | 297.33 | 302.52 | 293.66 |
| Jul-18 | 298.31 | 292.01 | 299.16 | 290.80 |
| Jul-21 | 292.01 | 293.12 | 296.56 | 291.47 |
| Jul-22 | 293.99 | 297.89 | 298.91 | 293.99 |
| Jul-23 | 300.69 | 305.61 | 306.92 | 299.02 |
| Jul-24 | 305.87 | 306.41 | 307.71 | 302.65 |
| Jul-25 | 306.80 | 304.50 | 307.27 | 302.11 |
| Jul-28 | 304.75 | 298.14 | 306.24 | 297.30 |
| Jul-29 | 299.19 | 297.56 | 302.14 | 296.85 |
| Jul-30 | 285.59 | 281.95 | 300.49 | 280.35 |
| Jul-31 | 283.25 | 274.70 | 284.00 | 272.12 |
| Aug-1 | 284.65 | 294.28 | 296.60 | 283.01 |
United Therapeutics Earnings
United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Forecast Revenue Growth
United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.65 per share, an increase next quarter of $0.87 per share, an increase this year of $1.90 per share, and an increase next year of $1.42 per share.
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.